Working groups

Click here for Educational Standards Working Group members’ area

Recommended Standards of Education and Training for Health Professionals Participating in Medicines Development

Background

The development of new medicines is a critical part of health innovation. Following the exponential advancement in the basic biomedical sciences and clinical medicine observed in the last 50 years, drug (medicines) development has become a complex set of disciplines with distinct scientific methodology and established needs for education.

The key disciplines in medicines development include clinical research, bioethics, drug safety, regulatory sciences, health economics and medical affairs. However, there is currently not a holistic approach and thus the education programmes available provide only partial knowledge of the entire process.

CIOMS is well positioned as a unique global and scientific organization to develop a multi-stakeholder consensus report related to harmonization guidelines for education and training in medicines development. The CIOMS guideline would serve as a worldwide reference for postgraduate programmes as well as for the competency-based knowledge needed for professionals working in pharmaceutical and biotechnology companies involved in product development and marketing.

Full concept note

Objectives

The main objective of this working group would be to discuss and develop a consensus report giving recommendations on the principles of competency-based knowledge needed for healthcare professionals working in medicines development.

In order to support this, the CIOMS WG would propose standard guidelines promoting harmonization across all stakeholders working in and providing education in medicines development.

Progress

  •      1st meeting held on 26-27 April 2021 (virtual meeting)
  •     2nd meeting held on 29 March 2022 (virtual meeting)

The Working Group (WG) makes the minutes of its in-person and virtual meetings public. Persons and parties not part of the WG are welcome to give their feedback. Please send your input to: batesc@cioms.ch.

 

CIOMS Working Groups usually take 2-4 years to finalize their consensus document and recommendations. Most groups hold two in-person meetings per year, with telework in between. The groups make use of collaborative efforts and capitalize on existing initiatives in order to provide output that is as comprehensive as possible, does not duplicate other efforts and has added value.

CIOMS MEETINGS

Upcoming Meetings

10 - 12 November 2022

Geneva, Switzerland

5th Meeting of the CIOMS WG on Good Governance Practice for Research Institutions

10 - 11 October 2022

Geneva, Switzerland

2nd Meeting for the Working Group on Artificial Intelligence in Pharmacovigilance

14 September 2022

Virtual

8th meeting of the WG XII on Benefit-Risk Balance for Medicinal Products

09 September 2022

Virtual

15th meeting of the Working Group XIII on Real-World Data & Evidence in Regulatory Decision-Making

06 - 07 September 2022

Geneva, Switzerland

3rd Meeting of the WG on Education and Training for Health Professionals

22 August 2022

Virtual

4th Meeting of the CIOMS WG on Good Governance Practice for Research Institutions

Recent Meetings